salicylhydroxamic acid: Clinical Trials

523 trials of salicylhydroxamic acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

283 completed, 73 recruiting, 66 unknown, 41 terminated. 295 Not applicable, 111 Phase 2, 85 Phase 3, 34 Phase 1, 19 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable295Completed 143, Recruiting 51, Unknown 48, Not yet recruiting 23, Terminated 16, Active not recruiting 6, Enrolling by invitation 3, Suspended 3, Withdrawn 2
Phase 2111Completed 65, Unknown 12, Recruiting 11, Terminated 10, Withdrawn 5, Active not recruiting 4, Not yet recruiting 3, Suspended 1
Phase 385Completed 58, Terminated 11, Recruiting 5, Unknown 4, Active not recruiting 2, Not yet recruiting 2, Withdrawn 2, Enrolling by invitation 1
Phase 134Completed 18, Recruiting 5, Not yet recruiting 3, Terminated 3, Active not recruiting 2, Unknown 2, Withdrawn 1
Phase 419Completed 10, Recruiting 3, Terminated 3, Unknown 2, Withdrawn 1
Early Phase 14Completed 2, Recruiting 2

Follow salicylhydroxamic acid: new trials by email Literature Review of salicylhydroxamic acid trials Research Report on salicylhydroxamic acid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Interactions Between Placebo Effects and Mindful Awareness State
tDCS stimulation (sham), tDCS stimulation (real), Mindful state induction - Placebo Effect, Mindfulness
Not applicableNot yet recruitingTrustees of Dartmouth College1202027-06-012026-10-07
Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery
Moxifloxacin, Placebo - Endophthalmitis
Phase 2 / Phase 3Not yet recruitingJason Ahee, M.D.600002027-06-012026-09-15
Spinal Manual Therapy Under Sedation
Spinal manual therapy under sedation, Sham - Spinal Pain
Not applicableNot yet recruitingSchweinhardt Petra202027-01-152026-10-08
Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery
BPC-157, Sham (No Treatment) - Rotator Cuff Tear
Phase 1Not yet recruitingUniversity of Arkansas302027-01-012026-09-03
Noninvasive Neuromodulation Of The Subjective Value Network In Chronic Pain
Transcranial magnetic stimulation, Sham - Chronic Neurogenic Pain
Phase 1Not yet recruitingNational Institute of Neurological Disorders and Stroke (NINDS)92026-12-012026-09-28
Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial
Faricimab, Sham - Central Serous Chorioretinopathy (CSC)
Phase 2Not yet recruitingSingapore National Eye Centre502026-12-012026-07-02
Osteopathic Care Combined With Physiotherapy and Pain Education for Cervicogenic Headache
Osteopathic Care, Physiotherapy, Sham (No Treatment) - Cervicogenic Headache
Not applicableNot yet recruitingCentro Universitário Augusto Motta1202026-11-012026-08-31
Mindful RAVANS Study
Cala-RAVANS (Model CR-2), Sham - mTBI - Mild Traumatic Brain Injury, Posttraumatic Stress Disorder
Not applicableNot yet recruitingSpaulding Rehabilitation Hospital202026-11-012026-10-14
Brain Dopamine Biomarker
Levadopa/Carbidopa eyedrops, Sham, Levodopa/Carbidopa (Sinemet) - Parkinson Disease, Healthy Adult Participants
Not yet recruitingUniversity of South Florida502026-10-012026-08-12
Extracorporeal Shockwave Therapy as an Additional Treatment for Spasticity Secondary to Spinal Cord Injury
Focused extracorporeal shockwave therapy, Botulinum toxin, Sham - Spinal Cord Injury, Spasticity
Phase 2RecruitingKessler Foundation302026-09-212026-10-26
Battlefield Acupressure for Acute Back Pain Management in the Emergency Department
Battlefield auricular acupressure, Sham - Acute Back Pain
Not applicableNot yet recruitingHackensack Meridian Health502026-09-102026-08-18
Transcranial Direct Current Stimulation for the Treatment of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors
Sham Intervention, Survey Administration, Transcranial Direct Current Stimulation - Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphatic System Neoplasm
Not applicableRecruitingUniversity of Michigan Rogel Cancer Center502026-09-102026-10-15
Optimizing Lymphatic Pumping for Influenza Vaccine Responses in Vulnerable Populations
Osteopathic Manipulation, Osteopathic manipulation, Sham - No Disease or Condition is Being Directly Studied, The Focus of the Study in Healthy Volunteers
Not applicableRecruitingLake Erie College of Osteopathic Medicine502026-09-012026-09-23
Acute Effects of Thoracolumbar Fascia Myofascial Release on Cortical Activity
Thoracolumbar Fascia Myofascial Release (Pilat MIF Crossed-Hands Technique), Sham (Light Surface Touch) - Healty Volunteers
Not applicableNot yet recruitingHitit University1242026-09-012026-07-29
Democratizing Access to Cleaner Residential Air
Portable air purifiers with HEPA filtration, Portable air purifiers without filtration (sham) - Cardiovascular (CV) Risk
Not applicableNot yet recruitingDouglas Brugge662026-09-012026-06-05
Placebo Effect in Field-Based Physical Performance
Caffeine (6mg/kg), Placebo (Starch capsule), Sham (No Treatment) - Physical Performance, Placebo Effect
Not applicableNot yet recruitingPoznan University of Physical Education1202026-09-012026-08-03
Transcranial Direct Current Stimulation to Improve Gait for Breast Cancer Survivor's Who Received Taxene and/or Platinum Chemotherapy
Sham Intervention, Survey Administration, Transcranial Direct Current Stimulation - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Not applicableNot yet recruitingUniversity of Michigan Rogel Cancer Center602026-09-012026-10-08
The Effect of Osteopathic Manipulative Techniques on Human Tear Composition
Osteopathic Manipulative Treatment, Sham - No Disease or Condition is Being Directly Studied, The Focus of the Study in Healthy Volunteers
Not applicableEnrolling by invitationLake Erie College of Osteopathic Medicine302026-09-012026-08-25
Single Session Personalized Aperiodic Transcranial Alternating Current Stimulation (PandA-tACS) for Antenatal Depression
Sham (placebo) tACS, IAF-tACS, PandA-tACS - Antenatal Depression
Not applicableNot yet recruitingUniversity of North Carolina, Chapel Hill602026-09-012026-09-02
A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
Oral BGE-102, Oral Placebo Matching BGE-102, Anti-VEGF - Diabetic Macular Edema (DME)
Phase 2RecruitingBioAge Labs, Inc.1802026-08-212026-10-27

Showing 20 of 523. Sign in to see all of them.

Conditions studied

Macular Degeneration (24)  ·  Macular Edema (23)  ·  Stroke (19)  ·  Diabetic Retinopathy (14)  ·  Geographic Atrophy (13)  ·  Low Back Pain (13)  ·  Retinal Vein Occlusion (13)  ·  Retinal Diseases (11)  ·  Spinal Cord Injuries (11)  ·  Vision Disorders (11)  ·  Pain (10)  ·  Diabetes Mellitus (9)  ·  Pulmonary Disease, Chronic Obstructive (9)  ·  Chronic Pain (8)  ·  Sleep Initiation and Maintenance Disorders (8)

Sponsors

Allergan (17)  ·  Novartis Pharmaceuticals (7)  ·  Genentech, Inc. (6)  ·  Alcon Research (5)  ·  McMaster University (4)  ·  Opthea Limited (4)  ·  Otonomy, Inc. (4)  ·  Spaulding Rehabilitation Hospital (4)  ·  ThromboGenics (4)  ·  University of California, San Diego (4)  ·  VA Office of Research and Development (4)  ·  Bayer (3)  ·  Brigham and Women's Hospital (3)  ·  Cairo University (3)  ·  Chengdu Kanghong Biotech Co., Ltd. (3)

Countries

United States (229)  ·  United Kingdom (45)  ·  France (40)  ·  Turkey (Türkiye) (40)  ·  Italy (39)  ·  Canada (38)  ·  Germany (36)  ·  Spain (35)  ·  China (34)  ·  Brazil (32)  ·  Israel (30)  ·  Australia (24)  ·  Poland (20)  ·  Czechia (19)  ·  South Korea (19)

Top investigators

Carl LeBel, PhD (4)  ·  Brendan L McNeish (2)  ·  David Duriancik, Ph.D. (2)  ·  Francesco Cerritelli, MS, DO (2)  ·  George F Wittenberg, MD, PhD (2)  ·  Jason Ehrlich, M.D., Ph.D. (2)  ·  Nathaniel M Schuster, MD (2)  ·  Pablo Velazquez-Martin, MD (2)  ·  Peter Nagele, MD, MSc (2)

Results publications

PMID 37314061, PMID 30957581, PMID 33206392, PMID 36774994, PMID 20008710, PMID 20427088, PMID 21571677, PMID 22965590, PMID 22999634, PMID 23415775, PMID 23699977, PMID 23706949, PMID 24768239, PMID 25148789, PMID 25439614, PMID 26050541, PMID 26452713, PMID 26519345, PMID 26581718, PMID 26584450, PMID 26802783, PMID 26985629, PMID 26992841, PMID 27234930, PMID 29752001, PMID 30419298, PMID 31047350, PMID 31047503, PMID 31654188, PMID 31668888, PMID 32134802, PMID 33383315, PMID 37260074, PMID 37585454, PMID 39680390, PMID 40634898, PMID 40688490, PMID 10217223, PMID 10568708, PMID 11468459, PMID 11873051, PMID 12204484, PMID 12853536, PMID 14685790, PMID 15596866, PMID 15750368, PMID 1588218, PMID 17080005, PMID 18496371, PMID 18534024

NIH funding

2017 (3), 2018 (3), 2014 (2), 2015 (2), 2019 (2), U10EY014229 (2), U10EY014231 (2), U10EY018817 (2), 1UM1HL113203-01A1 (1), 2005 (1), 2016 (1), I01CX002760 (1), K23AG090624 (1), P20GM121312 (1), R01HD081274 (1)